07:59 AM EDT, 06/24/2025 (MT Newswires) -- Bio-Techne ( TECH ) said Tuesday that it has entered a distribution agreement with US Pharmacopeia, which will allow the life sciences company to sell US Pharmacopeia's monoclonal antibody and recombinant adeno-associated virus reference standards alongside its analytical platforms.
Financial terms of the deal were not disclosed.